A lot of voices have been calling for a recession to start as early as this year. But whether we enter a recession this year or next, it’s better to be prepared. Luckily, Goldman Sachs has put its analysts to work, and the bank just released a report that includes the stocks it believes will […]
Read MoreKalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors. The company’s product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, an intravitreally administered plasma kallikrein inhibitor that is in Phase II […]
Read More